Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced central sympathetic activity in Parkinson's disease.
Krämer HH, Lautenschläger G, de Azevedo M, Doppler K, Schänzer A, Best C, Oertel WH, Reuter I, Sommer C, Birklein F. Krämer HH, et al. Among authors: lautenschlager g. Brain Behav. 2019 Dec;9(12):e01463. doi: 10.1002/brb3.1463. Epub 2019 Nov 5. Brain Behav. 2019. PMID: 31691543 Free PMC article.
Low threshold unmyelinated mechanoafferents can modulate pain.
Habig K, Schänzer A, Schirner W, Lautenschläger G, Dassinger B, Olausson H, Birklein F, Gizewski ER, Krämer HH. Habig K, et al. Among authors: lautenschlager g. BMC Neurol. 2017 Sep 15;17(1):184. doi: 10.1186/s12883-017-0963-6. BMC Neurol. 2017. PMID: 28915853 Free PMC article. Clinical Trial.
Processing of sensory, painful and vestibular stimuli in the thalamus.
Habig K, Krämer HH, Lautenschläger G, Walter B, Best C. Habig K, et al. Among authors: lautenschlager g. Brain Struct Funct. 2023 Mar;228(2):433-447. doi: 10.1007/s00429-022-02582-y. Epub 2022 Oct 14. Brain Struct Funct. 2023. PMID: 36239796 Free PMC article.
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas. Rummel M, et al. Lancet Oncol. 2016 Jan;17(1):57-66. doi: 10.1016/S1470-2045(15)00447-7. Epub 2015 Dec 5. Lancet Oncol. 2016. PMID: 26655425 Clinical Trial.
19 results